Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Sales | 761,500 | 681,800 | 608,000 | 515,100 | 481,800 |
| Cost of Goods | 335,200 | 297,000 | 262,100 | 223,500 | 208,700 |
| Gross Profit | 426,300 | 384,800 | 345,900 | 291,600 | 273,100 |
| Operating Expenses | 420,000 | 214,700 | 258,900 | 232,900 | 227,600 |
| Operating Income | 6,300 | 170,100 | 87,000 | 58,700 | 45,500 |
| Interest Expense | 43,900 | 12,200 | 9,800 | 11,500 | 10,500 |
| Other Income | 1,500 | -80,300 | -3,200 | -6,300 | -7,200 |
| Pre-tax Income | -36,100 | 77,600 | 74,000 | 40,900 | 27,800 |
| Income Tax | -8,200 | 19,400 | 18,500 | 7,000 | -3,100 |
| Net Income Continuous | -27,900 | 58,200 | 55,500 | 33,900 | 30,900 |
| Net Income | $-27,900 | $58,200 | $55,500 | $33,900 | $30,900 |
| EPS Basic Total Ops | -0.25 | 0.54 | 0.51 | 0.33 | 0.30 |
| EPS Basic Continuous Ops | -0.25 | 0.54 | 0.51 | 0.33 | 0.30 |
| EPS Diluted Total Ops | -0.25 | 0.53 | 0.51 | 0.33 | 0.30 |
| EPS Diluted Continuous Ops | -0.25 | 0.53 | 0.51 | 0.33 | 0.30 |
| EBITDA(a) | $97,500 | $178,900 | $159,000 | $122,000 | $115,100 |